[Genetics and molecular biology of the congenital, and acquired heart disease]

Related Experiment Video

Updated: Aug 10, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

David Cruz Robles1, Aurora de la Peña Díaz, Minerva Arce Fonseca

  • 1Departamento de Patología, Instituto Nacional de Cardiología, Ignacio Chávez, Tlalpan, México, DF. crumis@hotmail.com

Archivos De Cardiologia De Mexico
|March 21, 2006
PubMed

Insights

Molecular genetics advances aid in understanding and treating congenital heart defects, the most common birth defects. This review explores genetic insights for diagnosing and managing pediatric cardiac and vascular abnormalities.

Area of Science:

  • Developmental Biology: Focuses on the embryonic formation and function of the heart.
  • Medical Genetics: Investigates genetic factors influencing heart development and disease.
  • Pediatric Cardiology: Addresses congenital heart defects and related vascular abnormalities.

Context:

  • The heart is the first organ to develop, crucial for embryonic survival and development.
  • Congenital heart defects are the most common birth defects, affecting ~1% of newborns and significantly more in miscarriages.
  • Human genome sequencing provides a foundation for identifying genes related to heart development and disease.

Purpose:

  • To review the application of molecular and genetic analysis in pediatric cardiology.
  • To highlight the role of genetic discoveries in understanding the etiology and risk factors of cardiac and vascular abnormalities.
  • To discuss how genetic information aids in the diagnosis and treatment of heart disorders.

Summary:

  • Molecular genetic technologies, including chromosomal mapping, are increasingly used to identify genes involved in congenital heart defects.
  • These genetic insights are crucial for understanding both the primary causes and risk factors for cardiac and vascular abnormalities.
  • The review synthesizes current knowledge on molecular and genetic analysis for diagnosing and treating heart conditions.

Impact:

  • Accelerated discovery of genes responsible for monogenic traits impacting heart formation.
  • Improved diagnostic capabilities for congenital heart defects through genetic testing and analysis.
  • Potential for novel therapeutic strategies and personalized medicine approaches in pediatric cardiology.

More Related Videos

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods08:28

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods

Published on: March 10, 2020

In utero Measurement of Heart Rate in Mouse by Noninvasive M-mode Echocardiography08:01

In utero Measurement of Heart Rate in Mouse by Noninvasive M-mode Echocardiography

Published on: November 22, 2013

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...